Access this Article

Abstract

金沢大学大学院医学系研究科脳細胞分子学β-NAD+ is as abundant as ATP in neuronal cells. β-NAD+ functions not only as a coenzyme but also as a substrate. β-NAD+-utilizing enzymes are involved in signal transduction. We focus on ADP-ribosyl cyclase/CD38 which synthesizes cyclic ADP-ribose (cADPR), a universal Ca2+ mobilizer from intracellular stores, from β-NAD+. cADPR acts through activation/modulation of ryanodine receptor Ca2+ releasing Ca2+ channels. cADPR synthesis in neuronal cells is stimulated or modulated via different pathways and various factors. Subtype-specific coupling of various neurotransmitter receptors with ADP-ribosyl cyclase confirms the involvement of the enzyme in signal transduction in neurons and glial cells. Moreover, cADPR/CD38 is critical in oxytocin release from the hypothalamic cell dendrites and nerve terminals in the posterior pituitary. Therefore, it is possible that pharmacological manipulation of intracellular cADPR levels through ADP-ribosyl cyclase activity or synthetic cADPR analogues may provide new therapeutic opportunities for treatment of neurodevelopmental disorders. © 2007.

Journal

  • Neurochemistry International

    Neurochemistry International 51(2-4 SPEC. ISS.), 192-199, 2007-07-01

    Elsevier

Cited by:  2

Codes

  • NII Article ID (NAID)
    120001141007
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    0197-0186
  • Data Source
    CJPref  IR 
Page Top